Search
for
Sort by
Research 271–300 of 1000+
- Efficacy and Safety of Oral Dutasteride 0.5 mg Combined with Oral Minoxidil 2.5 mg for Male Androgenetic Alopecia: A Retrospective Cohort Study
- A0366 Comparative effects of finasteride and dutasteride on semen parameters in young men with androgenic alopecia: A randomized controlled study
- Suicidal ideation with finasteride but not dutasteride
- Sexual adverse events-related to dutasteride e finasteride: analysis of real-life data from Eudra-Vigilance database
- 004 Post Finasteride Syndrome: is Dutasteride Unfairly Accused?
- Faculty Opinions recommendation of Mesotherapy using dutasteride-containing preparation in treatment of female pattern hair loss: photographic, morphometric and ultrustructural evaluation.
- Finasteride, dutasteride: potential risk of suicidal ideation
- Similar Risk of Sexual Dysfunction in Androgenetic Alopecia Patients Treated With Dutasteride vs. Finasteride: A Retrospective Cohort Database Study
- From joint pains to hair gains: baricitinib’s double duty for rheumatoid arthritis and alopecia areata
- PSA concentration change in men taking low dose finasteride and dutasteride for male androgenetic alopecia
- MRI Regression Does Not Exclude Pathological Progression During Active Surveillance in Men Receiving Dutasteride
- Comparative study between topical minoxidil 5% and oral spironolactone versus topical minoxidil 5% and oral dutasteride in the treatment of women with androgenic alopecia
- FDA vetoes labelling proposals for finasteride, dutasteride
- Efficacy, safety and tolerability of dutasteride in male patients with male pattern hair Loss
- American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1
- Frontal fibrosing alopecia: A multicenter review of 355 patients
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- An overview on 5α-reductase inhibitors
- Medical treatments for male and female pattern hair loss
- Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men
- The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis
- Estrogen and androgen signaling in the pathogenesis of BPH
- Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men – short version
- Effect of Testosterone Supplementation With and Without a Dual 5α-Reductase Inhibitor on Fat-Free Mass in Men With Suppressed Testosterone Production
- Treatment of frontal fibrosing alopecia and lichen planopilaris: a systematic review
- Adverse effects of 5α-reductase inhibitors: What do we know, don’t know, and need to know?
- Appropriateness of oral drugs for long-term treatment of lower urinary tract symptoms in older persons: results of a systematic literature review and international consensus validation process (LUTS-FORTA 2014)
- Epidemiology and treatment modalities for the management of benign prostatic hyperplasia
- Androgenetic Alopecia: An Update of Treatment Options
- 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder